Bradley L. Radoff Reaches Agreement with Enzo Biochem for Board Representation and Governance Improvements

Activist Insight (subscription required) and other media sources reported on the agreement reached between Olshan client Bradley L. Radoff and Enzo Biochem pursuant to which two new directors, including Mr. Radoff, were appointed to the company’s Board of Directors and two incumbent directors resigned from the Board. As part of the agreement, Enzo Biochem also agreed to present a proposal to declassify its Board at its upcoming annual meeting of shareholders. Steve Wolosky, Ryan Nebel and Rebecca Van Derlaske represent Bradley L. Radoff in connection with his investment in Enzo Biochem.